DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
BRIGHT MINDS BIOSCIENCES INC.
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025
$53.82+2.52 (+4.91%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Sep 30, 2025
Bright Minds Biosciences reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Bright Minds Biosciences's annual report. Trading prices and yields need FINRA TRACE data.